Company · CIK 0001366541
Q Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 5Q Therapeutics, Inc.0001209191-16-098217 · 5.5 KBSEC(opens sec.gov)
- 5Q Therapeutics, Inc.0001209191-16-098169 · 5.1 KBSEC(opens sec.gov)
- 4/AQ Therapeutics, Inc.0001209191-16-098143 · 10.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-15-406382 · 13.5 KBSEC(opens sec.gov)
- 3Q Therapeutics, Inc.0001209191-15-081813 · 5.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-15-381074 · 50.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-15-376922 · 2.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-15-319570 · 95.8 KBSEC(opens sec.gov)
- 4Insider trades0001209191-15-070308 · 10.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-15-291454 · 2.3 MBSEC(opens sec.gov)
Insiders
- BORST STEVEN JOHNDirector, Chief Executive Officer
- EPPSTEIN DEBORAH ANNEDirector
- GOSWAMI JOYDEEPDirector
- GREBOW PETER EDirector
- Green David AChief Financial Officer
- HUTT PETER BARTONDirector
- Jorkasky DianeDirector
- PATEL DINESH CDirector
- Q Therapeutics, Inc.Chief Financial Officer
- Rao Mahendra S.Chief Strategy Officer
Tickers
No tickers on record.
Addresses
business
615 ARAPEEN DRIVE SUITE 102
SALT LAKE CITY, UT, 84108
mailing
615 ARAPEEN DRIVE SUITE 102
SALT LAKE CITY, UT, 84108
Former names
- Q Holdings, Inc.2012-12-18
- Grace 2, Inc.2011-12-02
Same industry